Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
Javier García‐Pérez(Instituto de Salud Carlos III), Mayte Pérez‐Olmeda(Instituto de Salud Carlos III)
Cited by 8
Related Papers
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
|Journal of Clinical Investigation|2021|110